Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 04 Jul 2026 · HPRA open data

Immedica Pharma AB — Licensed Medicines

9 medicines held by Immedica Pharma AB on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 9 products held by Immedica Pharma AB

Medicine	Active substance	Licence holder	Status
Ammonaps 500 mg Tablets EU/1/99/120/001	Sodium phenylbutyrate	Immedica Pharma AB	—
Ammonaps 500 mg Tablets EU/1/99/120/002	Sodium phenylbutyrate	Immedica Pharma AB	—
Ammonaps 940 mg/g Granules EU/1/99/120/003	Sodium phenylbutyrate	Immedica Pharma AB	—
Ammonaps 940 mg/g Granules EU/1/99/120/004	Sodium phenylbutyrate	Immedica Pharma AB	—
EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/001	Emedastine difumarate	Immedica Pharma AB	—
EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/003	Emedastine difumarate	Immedica Pharma AB	—
EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/004	Emedastine difumarate	Immedica Pharma AB	—
Loargys 5 mg/ml solution for injection/infusion EU/1/23/1774/001-002	Pegzilarginase	Immedica Pharma AB	—
RAVICTI 1.1 g/ml oral liquid EU/1/15/1062/001-004	Glycerol phenylbutyrate	Immedica Pharma AB	—

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.